Comparison of different definitions of the metabolic syndrome

Background The International Diabetes Federation (IDF) published a new definition of the metabolic syndrome (MetS). For this definition we compared frequency, concordance, clinical and laboratory stigmata and carotid atherosclerosis with those of the established definitions by the National Cholesterol Education Program (NCEP) and World Health Organization (WHO). Materials and methods A total of 1518 subjects (943 men, 575 women) from the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk (SAPHIR), free of clinical atherosclerosis, were included in this study. To estimate insulin sensitivity two methods, i.e. homeostasis model assessment of insulin resistance (HOMA-IR) and the short insulin tolerance test, were employed. Carotid intima media thickness (IMT) and plaque extent were quantified for all subjects using high-resolution ultrasound. Results Prevalence of the MetS was 18·7% for men and 16·2% for women for the WHO definition, 18·9% and 17·0%, respectively, for the NCEP definition, and 25·8% and 19·5%, respectively, for the IDF definition. Concordance was lower between the definitions of WHO and IDF ( 67%). Compared to subjects identified by NCEP definition, subjects identified in excess by IDF (3·1–11·7%) showed less insulin resistance and lower IMT and plaque extent indistinguishable from MetS-free subjects. Conclusions Our data suggest that the IDF definition includes subjects as MetS sufferers above these detected by NCEP or WHO, who exhibit considerably less insulin resistance and carotid atherosclerosis blurring the distinction between health and disease.